Muhammad Nauman Sher Zaman*

Optometrist, Bachelors of Vision Sciences Optometry, Al-Hamidiya Health Centre, Ajman, UAE

*Corresponding Author: Muhammad Nauman Sher Zaman, Optometrist, Bachelors of Vision Sciences Optometry, Al-Hamidiya Health Centre, Ajman, UAE.

Received: September 19, 2025; Published: October 28, 2025

Abstract

Introduction: Dyslipidemia is associated with a high risk of developing heart diseases and macrovascular diseases, such as stroke, particularly among diabetic patients. In Saudi Arabia, there is a need to evaluate the magnitude of dyslipidemia and aggravating factors that are associated with dyslipidemia among diabetic patients. The aim of this study is to assess prevalence of dyslipidemias, mainly high LDL, among T2DM diabetic patients.

Methods: This is a descriptive, hospital-based, and cross-sectional study recruited 100 patients with T2DM who have 2 readings of LDL, at least 6 months apart. Patients with diagnosed hypothyroidism or alcohol drinking were excluded from the study. A gender balanced sample of 50 males and 50 females at the age range of 18-75 years old were recruited from primary care department at Security Forces Hospital (SFH). The data was extracted form medical electronic records from 1st of January 2018 to 31st of December 2020. Multiple linear regression were used to determine the significant predictors of LDL level.

Results: A total of 100 patients with T2DM included with mean age of 57.3 ± 7.7. About a third of the patients had high LDL level in both readings, compared to 21% had low level of HDL. The mean level of LDL was higher in females than in males but the differences were not statistically significant. An improvement in glycemic control among the included patients when comparing baseline and follow-up level of HbAc1. Concerning gender difference in dyslipidemia, the present study showed that levels of all dyslipidemia parameters were higher in females than in males but significant difference only detected in T. cholesterol and HDL. Change-rate in T. cholesterol level, change-rate in triglyceride level, and change-rate in HDL level were significant predictors for change-rate in LDL level. The change-rate in LDL level increased by 0.89 mg/dl for one unit rise in T. cholesterol change-rate. Differently, the change-rate in LDL level decreased by 0.36 or 0.54 mg/dl for one unit rise in triglycerides or HDL change-rate, respectively.

Conclusions: Based on robust estimations, a considerable proportion of diabetic patients had abnormal levels of dyslipidemia parameters, particularly LDL level. The change rate in lipid profile could be considered as a rough indicator for the effect of self-control or therapy in this study. An improvement in glycemic control was found when comparing baseline and follow-up level of HbAc1. Change-rate in T. cholesterol level, change-rate in triglyceride level, and change-rate in HDL level were significant predictors for change-rate in LDL level.

Keywords: Dyslipidemia; High Cholesterol; Atherosclerosis; Glycemic Control; Hyperglycemia

References

1. Naeem Z. “Burden of diabetes mellitus in Saudi Arabia”. International Journal of Health Sciences3 (2015): V.
2. Organization WH. “Prevention of diabetes mellitus: report of a WHO study group [meeting held in Geneva from 16 to 20 November 1992]”. World Health Organization; (1994).
3. Abdulaziz Al Dawish M., et al. “Diabetes mellitus in Saudi Arabia: a review of the recent literature”. Current Diabetes Reviews4 (2016): 359-368.
4. Association AD. “Classification and diagnosis of diabetes: standards of medical care in diabetes—2019”. Diabetes Care1 (2019): S13-S28.
5. Weng J. “Evolution in the Chinese diabetes society standards of care for type 2 diabetes”. Diabetes/Metabolism Research and Reviews5 (2016): 440-441.
6. Kundu D., et al. “Study of the correlation between total lipid profile and glycosylated hemoglobin among the indigenous population of Guwahati”. International Journal of Life Sciences Research (IJLSR) 4 (2017): 1175-1180.
7. Naqvi S., et al. “Correlation between glycated hemoglobin and triglyceride level in type 2 diabetes mellitus”. Cureus6 (2017).
8. Naeem M., et al. “The role of glycated hemoglobin (HbA1c) and serum lipid profile measurements to detect cardiovascular diseases in type 2 diabetic patients”. South East Asia Journal of Public Health2 (2015): 30-34.
9. Baranwal JK., et al. “Association between level of HbA1c and lipid profile in T2DM patients attending diabetic OPD at BPKIHS”. Health Renaissance3 (2015): 16-23.
10. Yazdanpanah S., et al. “Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: a comprehensive review”. Critical Reviews in Clinical Laboratory Sciences4 (2017): 219-232.
11. Sarkar S and Meshram A. “HbA1c and lipid profile levels in the known type 2 diabetic group in the rural region of Vidarbha, Maharashtra, India”. Journal of Evidence-Based Medicine and Healthcare 4 (2017): 1915-1920.
12. Samdani TS., et al. “Relationship of glycated haemoglobin with lipid profile among patients with type 2 diabetes mellitus”. Birdem Medical Journal1 (2017): 43-47.
13. Alzahrani SH., et al. “Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 12 (2019): 1639.
14. Bloomgarden ZT. “Insulin resistance, dyslipidemia, and cardiovascular disease”. Diabetes Care8 (2007): 2164-2170.
15. Buse JB., et al. “Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association”. Circulation 1 (2007): 114-126.
16. O'Keefe JH., et al. “Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach”. In, Mayo Clinic Proceedings: Elsevier; (2009): 741-757.
17. Savelieff MG., et al. “The emerging role of dyslipidemia in diabetic microvascular complications”. Current Opinion in Endocrinology, Diabetes and Obesity2 (2020): 115-123.
18. Sami W and Ab Hamid M. “Lipid profile of type 2 diabetics in Almajmaah, Saudi Arabia”. In, Journal of Physics: Conference Series: IOP Publishing; (2019): 012131.
19. Alzaheb RA and Altemani AH. “Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 13 (2020): 4033.
20. Bayram F., et al. “Prevalence of dyslipidemia and associated risk factors in Turkish adults”. Journal of Clinical Lipidology2 (2014): 206-216.
21. Habib SS. “Gender differences in lipid and glycemic control in Saudi patients with type 2 diabetes mellitus”. Rawal Medical Journal1 (2013): 22-25.
22. Silva EFd., et al. “Optimal Cutoff of the TG/HDL-c ratio for Cardiovascular Risk in Hypertensive and Diabetic Patients Monitored by Primary Health Care in a city in Minas Gerais”. International Journal of Cardiovascular Sciences 34 (2021): 55-65.
23. Turk-Adawi K., et al. “Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden”. Nature Reviews Cardiology2 (2018): 106-119.

Citation

Citation: Abdullah Saeed Alqahtani., et al. “The Prevalence of high LDL-C Among Diabetic Patients Type 2, Security Forces Hospital, Riyadh, Saudi Arabia".Acta Scientific Ophthalmology 8.11 (2025): 16-28.

Copyright

Copyright: © 2025 Abdullah Saeed Alqahtani., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.